Dexamethasone

Multiple Myeloma	28.6%
Product Used For Unknown Indication	18.3%
Acute Lymphocytic Leukaemia	12.5%
Prophylaxis	7.4%
Plasma Cell Myeloma	6.3%
Drug Use For Unknown Indication	3.4%
Thrombosis Prophylaxis	2.9%
Hypertension	2.8%
Pain	2.3%
Breast Cancer	2.1%
Chemotherapy	1.7%
Prostate Cancer	1.7%
Prophylaxis Of Nausea And Vomiting	1.6%
Non-hodgkin's Lymphoma	1.5%
Diffuse Large B-cell Lymphoma	1.2%
Hodgkin's Disease	1.2%
Back Pain	1.1%
Anaesthesia	1.1%
B Precursor Type Acute Leukaemia	1.1%
Glioblastoma Multiforme	1.1%

Thrombosis	11.8%
Thrombocytopenia	10.7%
Vomiting	8.0%
Neuropathy Peripheral	6.5%
Pneumonia	6.5%
Sepsis	5.8%
Renal Vein Thrombosis	5.3%
Osteonecrosis	4.9%
Pyrexia	4.5%
Pulmonary Embolism	4.2%
Tumour Lysis Syndrome	4.0%
Exposure During Pregnancy	3.6%
Deep Vein Thrombosis	3.3%
Neutropenia	3.3%
Posterior Reversible Encephalopathy Syndrome	3.3%
Drug Ineffective	3.1%
Febrile Neutropenia	3.1%
Dyspnoea	2.9%
Infection	2.7%
Renal Failure Acute	2.7%

Secondary

Multiple Myeloma	28.7%
Product Used For Unknown Indication	16.1%
Prophylaxis	9.5%
Plasma Cell Myeloma	8.9%
Acute Lymphocytic Leukaemia	8.5%
Drug Use For Unknown Indication	5.7%
Mantle Cell Lymphoma	3.7%
Hypertension	2.8%
Thrombosis Prophylaxis	2.2%
Pain	1.9%
Burkitt's Lymphoma	1.9%
Prophylaxis Of Nausea And Vomiting	1.4%
Non-hodgkin's Lymphoma	1.4%
Constipation	1.3%
Infection Prophylaxis	1.2%
Burkitt's Leukaemia	1.1%
Amyloidosis	1.0%
Breast Cancer	0.9%
Nausea	0.8%
Adverse Event	0.8%

Death	10.3%
Thrombocytopenia	10.3%
Sepsis	8.1%
Pneumonia	8.0%
Pyrexia	7.4%
Vomiting	6.0%
Neutropenia	4.9%
Febrile Neutropenia	4.6%
White Blood Cell Count Decreased	4.3%
Renal Failure	4.2%
Pulmonary Embolism	4.1%
Septic Shock	4.0%
Myelodysplastic Syndrome	3.4%
Renal Failure Acute	3.1%
Platelet Count Decreased	3.1%
Pancytopenia	2.9%
Infection	2.9%
Plasma Cell Myeloma	2.9%
Multiple Myeloma	2.8%
Urinary Tract Infection	2.8%

Concomitant

Product Used For Unknown Indication	22.5%
Drug Use For Unknown Indication	12.9%
Multiple Myeloma	12.9%
Prophylaxis	10.6%
Non-small Cell Lung Cancer	4.9%
Pain	4.8%
Premedication	4.5%
Breast Cancer	4.1%
Plasma Cell Myeloma	4.0%
Nausea	3.6%
Hypertension	3.0%
Constipation	1.8%
Chemotherapy	1.7%
Prophylaxis Of Nausea And Vomiting	1.7%
Depression	1.3%
Acute Lymphocytic Leukaemia	1.2%
Prostate Cancer	1.2%
Vomiting	1.2%
Colorectal Cancer Metastatic	1.0%
Colorectal Cancer	1.0%

Vomiting	11.9%
Death	11.1%
Thrombocytopenia	9.5%
Pneumonia	7.0%
Weight Decreased	5.7%
Pulmonary Embolism	5.1%
Sepsis	5.1%
White Blood Cell Count Decreased	4.8%
Pyrexia	4.8%
Renal Failure Acute	3.8%
Neutropenia	3.8%
Multiple Myeloma	3.7%
Renal Failure	3.2%
Plasma Cell Myeloma	3.2%
Pancytopenia	3.1%
Dyspnoea	2.9%
Febrile Neutropenia	2.9%
Toxicity To Various Agents	2.9%
Respiratory Failure	2.9%
Rash	2.7%

Interacting

Product Used For Unknown Indication	28.4%
General Anaesthesia	11.1%
Glioblastoma Multiforme	6.2%
Drug Use For Unknown Indication	5.2%
Pain	5.2%
Multiple Myeloma	4.6%
Hiv Infection	3.9%
Neuralgia	3.9%
Spinal Cord Compression	3.9%
Adrenogenital Syndrome	3.3%
Plasma Cell Myeloma	3.3%
Hepatosplenic Candidiasis	2.9%
Bone Pain	2.6%
Constipation	2.6%
Hyperlipidaemia	2.6%
Convulsion	2.3%
Cancer Pain	2.0%
Cystoid Macular Oedema	2.0%
Cytomegalovirus Chorioretinitis	2.0%
Maintenance Of Anaesthesia	2.0%

Drug Interaction	27.9%
Ophthalmoplegia	8.2%
Rhabdomyolysis	8.2%
Myotonia	6.6%
Rash	4.9%
Sinoatrial Block	4.9%
Urosepsis	4.9%
Weight Increased	4.9%
Muscle Haemorrhage	3.3%
Pulmonary Embolism	3.3%
Sinus Tachycardia	3.3%
Skin Exfoliation	3.3%
Swelling	3.3%
Tremor	3.3%
Adrenal Suppression	1.6%
Arrhythmia	1.6%
Bone Marrow Failure	1.6%
Diarrhoea	1.6%
Drug Level Decreased	1.6%
Gastrointestinal Inflammation	1.6%